Germ cell responses to doxorubicin exposure in vitro

Khaled Habas1, Diana Anderson1, Martin H Brinkworth1

  • 1School of Medical Sciences, Faculty of Life Sciences, University of Bradford, Bradford, Richmond Road, West Yorkshire, BD7 1DP, UK.

Toxicology Letters
|November 29, 2016
PubMed

Insights

Doxorubicin (Dox) causes DNA damage and apoptosis in mouse germ cells. Pre-meiotic spermatogonia and meiotic spermatocytes are highly susceptible to this chemotherapy-induced testicular toxicity.

Area of Science:

  • Reproductive toxicology
  • Cancer chemotherapy
  • Molecular biology

Background:

  • Anthracyclines like doxorubicin (Dox) are vital in cancer treatment.
  • Doxorubicin is known to induce testicular toxicity and oxidative stress.
  • Understanding germ cell sensitivity to Dox is crucial for fertility preservation.

Purpose of the Study:

  • To investigate if doxorubicin induces DNA damage and apoptosis in mouse germ cells.
  • To determine the concentration-dependent effects of doxorubicin on germ cells.
  • To identify the most susceptible germ cell types to doxorubicin toxicity.

Main Methods:

  • Isolated mouse germ cells were exposed to varying concentrations of doxorubicin (0.05, 0.5, 1mM).
  • DNA damage was quantified using the Comet assay (single cell gel electrophoresis).
  • Apoptosis was assessed via TUNEL assay.

Main Results:

  • Doxorubicin exposure significantly increased DNA damage and apoptosis in germ cells.
  • The incidences of DNA damage and apoptosis showed a concentration-dependent increase with doxorubicin.
  • Pre-meiotic spermatogonia and meiotic spermatocytes exhibited high susceptibility to doxorubicin.

Conclusions:

  • Apoptosis is a key mechanism in doxorubicin-induced testicular toxicity.
  • Germ cell toxicity from doxorubicin is phase-specific.
  • Spermatogonia and spermatocytes are particularly vulnerable to doxorubicin treatment.

Related Concept Videos